| P2093 | author name string | Zhen Wang | |
| | Larry J Prokop | |
| | Mohammad Hassan Murad | |
| | Brian J McMahon | |
| | John B Wong | |
| | Anna S F Lok | |
| | Robert S Brown | |
| | Khaled Mohammed | |
| | Ahmed T Ahmed | |
| | Mohamed A Mouchli | |
| P2860 | cites work | Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. | Q42678962 |
| | Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. | Q42947269 |
| | Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years | Q43914060 |
| | A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children | Q44524987 |
| | Long-term safety of lamivudine treatment in patients with chronic hepatitis B. | Q44729211 |
| | Vertical Transmission of Hepatitis B Antigen in Taiwan | Q45146867 |
| | The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus | Q45359804 |
| | Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. | Q45387049 |
| | Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load | Q45781809 |
| | Incidence of hepatitis B virus infections in preschool children in Taiwan. | Q45792725 |
| | Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma | Q45796339 |
| | Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection | Q45830698 |
| | Telbivudine During the Second and Third Trimester of Pregnancy Interrupts HBV Intrauterine Transmission: A Systematic Review and Meta-analysis | Q57570869 |
| | Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F | Q81404746 |
| | Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B | Q82822290 |
| | Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers | Q83218996 |
| | Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B | Q83462911 |
| | Chronic hepatitis B: update 2009 | Q29617409 |
| | Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials | Q29620299 |
| | Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy | Q33417353 |
| | Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis | Q33611824 |
| | Interruption of HBV intrauterine transmission: a clinical study | Q33967082 |
| | Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection | Q33981964 |
| | Hepatitis B: global importance and need for control | Q34169834 |
| | The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies | Q34304280 |
| | AASLD guidelines for treatment of chronic hepatitis B. | Q34501660 |
| | Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice | Q34805931 |
| | A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus | Q35545742 |
| | Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy | Q35659264 |
| | Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants | Q36333957 |
| | Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection | Q37439967 |
| | Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry | Q38024218 |
| | How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature | Q38227467 |
| | Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus | Q41349327 |
| | Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus | Q42207494 |
| | Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. | Q42216418 |
| | Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization | Q42227338 |
| | A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection | Q42606604 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| | systematic review | Q1504425 |
| | chronic hepatitis B | Q55779876 |
| | chronic hepatitis | Q62019625 |
| P304 | page(s) | 319-333 | |
| P577 | publication date | 2015-11-13 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis | |
| P478 | volume | 63 | |